You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The GeneReader NGS system, which is geared toward clinical laboratories, is an integrated package with multiple components that cover all steps to analyze a tissue sample.
AmoyDx will develop and commercialize a series of oncology tests that use Illumina NGS technology, including the firm's TruSight Tumor 15 panel.
Under the terms of the agreement, N-of-One will provide clinical interpretation services for samples sequenced on a 50-gene hot-spot solid tumor panel.
The firm is conducting a multi-center prospective clinical study to validate its liquid biopsy ctDNA test, which it plans to launch for pharma customers this year and commercially in 2016.
Gene panel testing of cancer patients helps clinicians identify actionable mutations, according to presenters at this year's AACC meeting.
EDGC will have exclusive distribution rights in South Korea for the OncoDEEP Dx panel and other technologies, while physicians there will be able to access the OncoShare web platform.
Last month, the company presented results from a pilot study at the Worldwide Innovative Networking (WIN) Symposium in Paris.
Deck: The panels, which cover lung, colon, brain, and thyroid cancer as well as melanoma and gastrointestinal stromal tumors, target newly diagnosed patients.
So far, results from the MSK-IMPACT test have been reported for more than 4,500 patients.
The UCSF spinout was founded last year and has been selling an FFPE DNA extraction kit and three NGS cancer panels.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.